Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
HIKAL is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹2,751.4 Cr 3.9% 16.3% -40.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,048.0 Cr 0.5% 4.6% 11.7% Stock Analytics
DIVIS LABORATORIES ₹177,179.0 Cr -0.6% 2.2% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,804.0 Cr 3.2% 8.1% 43.9% Stock Analytics
CIPLA ₹117,642.0 Cr 1.1% 5.6% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹112,368.0 Cr -0.3% 5.6% -0.1% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

3.9%

16.3%

-40.4%

SENSEX

0.7%

4.4%

-5.6%


You may also like the below Video Courses